Dear Doctor Letter (Rote-Hand-Brief) on Strattera® (atomoxetine): Risk of increased blood pressure and/or heart rate
2011.12.13
Active substance: atomoxetine
Important safety-relevant information on the risk of increased blood pressure and/or heart rate associated with the use of Strattera® (atomoxetine) for treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
Additional information (available in German only):
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN